<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04950179</url>
  </required_header>
  <id_info>
    <org_study_id>PDRI-2020</org_study_id>
    <nct_id>NCT04950179</nct_id>
  </id_info>
  <brief_title>PDRI Rates Among CAPD Patients at a Tertiary University Hospital: A 5-Year Retrospective Study</brief_title>
  <official_title>Peritoneal Dialysis-Related Infection Rates and Outcomes of Antibiotic Treatments Among Continuous Ambulatory Peritoneal Dialysis Patients at a Tertiary University Hospital: A 5-Year Retrospective Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Phramongkutklao College of Medicine and Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Silpakorn University Faculty of Pharmacy</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Phramongkutklao College of Medicine and Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Peritoneal dialysis-related infection is a complication that leads to peritoneal dialysis&#xD;
      catheter removal or patient death. The present study aimed to investigate peritoneal&#xD;
      dialysis-related infection rates, causative pathogens, appropriation of antibiotic use,&#xD;
      treatment outcomes and trend in antimicrobial resistance of causative pathogens.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">February 24, 2021</start_date>
  <completion_date type="Actual">April 14, 2021</completion_date>
  <primary_completion_date type="Actual">March 11, 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Rate of peritoneal dialysis-related infection</measure>
    <time_frame>January 1, 2016 to December 31, 2020</time_frame>
    <description>Retrospective data collection from patients' medical records</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Treatment outcomes of peritoneal dialysis-related infection</measure>
    <time_frame>January 1, 2016 to December 31, 2020</time_frame>
    <description>Retrospective data collection from patients' medical records</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Causative pathogens of peritoneal dialysis-related infection</measure>
    <time_frame>January 1, 2016 to December 31, 2020</time_frame>
    <description>Retrospective data collection from patients' medical records</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Appropriation of antibiotic use in the treatments of peritoneal dialysis-related infection</measure>
    <time_frame>January 1, 2016 to December 31, 2020</time_frame>
    <description>Retrospective data collection from patients' medical records</description>
  </secondary_outcome>
  <enrollment type="Actual">135</enrollment>
  <condition>Peritoneal Dialysis-related Infection</condition>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>PDRI patients</intervention_name>
    <description>The study was conducted by retrospective data collection from medical records of 135 continuous ambulatory peritoneal dialysis (CAPD) patients at Phramongkutklao Hospital from January 1, 2016 to December 31, 2020.</description>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients who were undergoing Continuous Ambulatory Peritoneal Dialysis (CAPD) at CAPD&#xD;
        clinic, Phramongkutklao Hospital.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. Patients who were at least 18 years old.&#xD;
&#xD;
          2. Patients who were diagnosed with stage 5 chronic kidney disease (eGFR &lt; 15&#xD;
             ml/min/1.73m^2).&#xD;
&#xD;
          3. Patients who were undergoing Continuous Ambulatory Peritoneal Dialysis (CAPD) at CAPD&#xD;
             clinic, Phramongkutklao Hospital during January 1, 2016 to December 31, 2020.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. Patients with incomplete data records that invalid to include in the process of data&#xD;
             analysis&#xD;
&#xD;
          2. Patients who were not treated and started their first CAPD at CAPD clinic,&#xD;
             Phramongkutklao Hospital.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Pamila Tasanavipas, MD</last_name>
    <role>Study Chair</role>
    <affiliation>Phramongkutklao Hospital and College of Medicine</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Daraporn Rungprai, BCP</last_name>
    <role>Study Director</role>
    <affiliation>Faculty of Pharmacy, Silpakorn University</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Vorada Pengsong</last_name>
    <role>Principal Investigator</role>
    <affiliation>Faculty of Pharmacy, Silpakorn University</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Vattanai Dhamnimitchok</last_name>
    <role>Principal Investigator</role>
    <affiliation>Faculty of Pharmacy, Silpakorn University</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Vilai Wisuthip</last_name>
    <role>Principal Investigator</role>
    <affiliation>Faculty of Pharmacy, Silpakorn University</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Supichaya Hluangbumroong</last_name>
    <role>Principal Investigator</role>
    <affiliation>Faculty of Pharmacy, Silpakorn University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Phramongkutklao Hospital</name>
      <address>
        <city>Ratchathewi</city>
        <state>Bangkok</state>
        <zip>10400</zip>
        <country>Thailand</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Thailand</country>
  </location_countries>
  <reference>
    <citation>Luvira V, Satirapoj B, Supasyndh O, Chaiprasert A, Ruangkanchanasetr P, Nata N, Kanjanakul I, Supaporn T, Choovichian P, Bijaphala S, Luvira U, Phiboonbanakit D. A single-centre experience: peritoneal dialysis-related infections in patients on long-term dialysis. J Med Assoc Thai. 2011 Sep;94 Suppl 4:S30-6.</citation>
    <PMID>22043564</PMID>
  </reference>
  <reference>
    <citation>Kanjanabuch T, Chancharoenthana W, Katavetin P, Sritippayawan S, Praditpornsilpa K, Ariyapitipan S, Eiam-Ong S, Dhanakijcharoen P, Lumlertgul D. The incidence of peritoneal dialysis-related infection in Thailand: a nationwide survey. J Med Assoc Thai. 2011 Sep;94 Suppl 4:S7-12.</citation>
    <PMID>22043560</PMID>
  </reference>
  <reference>
    <citation>Perl J, Fuller DS, Bieber BA, Boudville N, Kanjanabuch T, Ito Y, Nessim SJ, Piraino BM, Pisoni RL, Robinson BM, Schaubel DE, Schreiber MJ, Teitelbaum I, Woodrow G, Zhao J, Johnson DW. Peritoneal Dialysis-Related Infection Rates and Outcomes: Results From the Peritoneal Dialysis Outcomes and Practice Patterns Study (PDOPPS). Am J Kidney Dis. 2020 Jul;76(1):42-53. doi: 10.1053/j.ajkd.2019.09.016. Epub 2020 Jan 10.</citation>
    <PMID>31932094</PMID>
  </reference>
  <reference>
    <citation>Wang HH, Huang CH, Kuo MC, Lin SY, Hsu CH, Lee CY, Chiu YW, Chen YH, Lu PL. Microbiology of peritoneal dialysis-related infection and factors of refractory peritoneal dialysis related peritonitis: A ten-year single-center study in Taiwan. J Microbiol Immunol Infect. 2019 Oct;52(5):752-759. doi: 10.1016/j.jmii.2018.10.013. Epub 2019 Jan 8.</citation>
    <PMID>30665844</PMID>
  </reference>
  <reference>
    <citation>Chen HC, Shieh CC, Sung JM. Increasing Staphylococcus Species Resistance in Peritoneal Dialysis-Related Peritonitis over a 10-Year Period in a Single Taiwanese Center. Perit Dial Int. 2018 Jul-Aug;38(4):266-270. doi: 10.3747/pdi.2017.00226.</citation>
    <PMID>29987065</PMID>
  </reference>
  <reference>
    <citation>Li PK, Szeto CC, Piraino B, Bernardini J, Figueiredo AE, Gupta A, Johnson DW, Kuijper EJ, Lye WC, Salzer W, Schaefer F, Struijk DG; International Society for Peritoneal Dialysis. Peritoneal dialysis-related infections recommendations: 2010 update. Perit Dial Int. 2010 Jul-Aug;30(4):393-423. doi: 10.3747/pdi.2010.00049. Erratum in: Perit Dial Int. 2011 Sep-Oct;31(5):512.</citation>
    <PMID>20628102</PMID>
  </reference>
  <reference>
    <citation>Szeto CC, Li PK, Johnson DW, Bernardini J, Dong J, Figueiredo AE, Ito Y, Kazancioglu R, Moraes T, Van Esch S, Brown EA. ISPD Catheter-Related Infection Recommendations: 2017 Update. Perit Dial Int. 2017 Mar-Apr;37(2):141-154. doi: 10.3747/pdi.2016.00120. Review.</citation>
    <PMID>28360365</PMID>
  </reference>
  <reference>
    <citation>Li PK, Szeto CC, Piraino B, de Arteaga J, Fan S, Figueiredo AE, Fish DN, Goffin E, Kim YL, Salzer W, Struijk DG, Teitelbaum I, Johnson DW. ISPD Peritonitis Recommendations: 2016 Update on Prevention and Treatment. Perit Dial Int. 2016 Sep 10;36(5):481-508. doi: 10.3747/pdi.2016.00078. Epub 2016 Jun 9. Review. Erratum in: Perit Dial Int. 2018 Jul-Aug;38(4):313.</citation>
    <PMID>27282851</PMID>
  </reference>
  <verification_date>July 2021</verification_date>
  <study_first_submitted>June 25, 2021</study_first_submitted>
  <study_first_submitted_qc>June 25, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">July 6, 2021</study_first_posted>
  <last_update_submitted>July 6, 2021</last_update_submitted>
  <last_update_submitted_qc>July 6, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">July 12, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Peritoneal dialysis-related infection</keyword>
  <keyword>Infectious peritonitis</keyword>
  <keyword>Exit-site infection</keyword>
  <keyword>Tunnel infection</keyword>
  <keyword>Infection rate</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Infections</mesh_term>
    <mesh_term>Communicable Diseases</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

